Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics.
Ontology highlight
ABSTRACT: Countless expectations converge in the multidisciplinary endeavour for the search and development of effective and safe drugs in fighting cancer. Although they still embody a minority of the pharmacological agents currently in clinical use, metal-based complexes have great yet unexplored potential, which probably hides forthcoming anticancer drugs. Following the historical success of cisplatin and congeners, but also taking advantage of conventional chemotherapy limitations that emerged with applications in the clinic, the design and development of non-platinum metal-based chemotherapeutics, either as drugs or prodrugs, represents a rapidly evolving field wherein candidate compounds can be fine-tuned to access interactions with druggable biological targets. Moving in this direction, over t
SUBMITTER: Ferraro MG
PROVIDER: S-EPMC9147010 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA